NCT02005107View on ClinicalTrials.gov

Venlafaxine PK Following Bariatric Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Roux en Y Gastric BypassSleeve Gastrectomy
Interventions
DRUG

Venlafaxine IR and Venlafaxine XR

Trial Locations (1)

58103

Neuropsychiatric Research Institute, Fargo

All Listed Sponsors
collaborator

Neuropsychiatric Research Institute, Fargo, North Dakota

OTHER

lead

North Dakota State University

OTHER

NCT02005107 - Venlafaxine PK Following Bariatric Surgery | Biotech Hunter | Biotech Hunter